Welcome Message

Dear Colleagues,

It is with great pleasure that I cordially invite you to the 2022 KAI International Meeting of the Korean Association of Immunologists.

This year's meeting will be held at Songdo Convensia in Songdo, Incheon for three days from November 3rd (Thu) to November 5th (Sat). Due to the SARS-CoV-2 pandemic, KAI Meetings have been held online for the past two years, but this year the meeting will focus on offline meetings and events.

To mark the occasion of our first offline meeting in 3 years, the 2022 KAI International Meeting offers academically high-level programs featuring 4 plenary lectures and 17 symposiums by prominent domestic and international leaders of immunology and clinical research.

Plenary lectures will be given by KAI-Genexine Awardees, and Drs. Steffen Jung, Daniel Cua, and Donna Farber have been tapped to discuss the latest information on the emerging topic of immunological research. The symposium consists of a total of 17 topics, from basic research on innate/adaptive immunity/immunometabolism to topics on immune diseases such as vaccines, allergies, autoimmunity, and cancer. In particular, specialized programs in clinical immunology on autoimmune diseases and clinical cancer immunology will be the primary focus on the second and third day for immunology and company researchers, clinicians, and practitioners of the field. In addition, a Young Immunologist Session has been coordinated to share the research achievements of next-generation immunologists, including graduate students and researchers dedicated to extending the reach of immunology into the future.

This year, as the meeting is held in Incheon, the nexus of the Korean bio industry, a "KAI-Songdo Immuno Bio Forum" event will also be held in collaboration with Incheon City, corporates, and investors during the event period. Through this forum, the industrial, academic, research, and government sectors will coalesce to discuss the current status of the Korean immunotherapy industry and share strategies for future research.

I ask for your interest and enthusiasm in revitalizing academic, person-to-person exchanges among immunologists. Join us in establishing KAI International Meetings as a preeminent academic conference attracting the brightest scholars the world over. I look forward to seeing you in Songdo in good health.

Wan-Uk Kim, MD/PhD President
Korean Association of Immunologists